Teplizumab effective in maintaining β-cell function in type 1 diabetes
1. In this randomized-controlled trial, two 12-day courses of teplizumab improved C-peptide levels compared to placebo at week 78 in ...
Tag: β-cell
Baricitinib protects β-cell function in new-onset type 1 diabetes
1. In this randomized controlled trial, the Janus kinase (JAK) inhibitor baricitinib was associated with preserved β-cell function compared to ...
